During subchronic corticosterone exposure, CORT125281 at 60 mg/kg/day partially restored corticosterone-induced hyperinsulinemia, but was inferior to a similar dose of mifepristone in reversing corticosterone effects on immune cells and the expression of GR target genes. The gene discussed is NR3C1; the disease is Hyperinsulinemia.